$145.72
-3.08-2.07%
近くで: Sep 4, 5:00 PM EST
$145.00
-0.72-0.49%
時間外: 5:30 PM EST
Benzinga
Benzinga
Benzinga
土曜日, 9 05
Protagonist Therapeutics Inc
PTGXNASDAQ
Protagonist Therapeutics Earnings & Forecasts
Protagonist Therapeutics (PTGX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Protagonist Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.84 | $-0.65 | $-0.54 | $-0.62 |
| Actual | $2.29 | $0.05 | $-0.69 | $-0.62 |
| Surprise | +24.5% | +107.7% | -27.8% | 0.00% |
| Revenue | ||||
| Estimate | $213.1M | $14.0M | $14.3M | $6.5M |
| Actual | $213.5M | $56.4M | $7.4M | $4.7M |
| Surprise | +0.16% | +302.1% | -47.9% | -27.3% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.52 | $-0.48 | $-0.75 | $-0.52 |
| Revenue | ||||
| Consensus | $248.1M | $31.7M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved